Filing
Spy
Filing
Spy
Home
About
ALVO
Alvotech SA
Biosimilar pharmaceutical developer and manufacturer
CUSIP: L01800108
Healthcare
IS
1 holder
Ownership
Activity
2023 Q3
10 of 15 quarters
Total Value
$46.00B
Total Shares
5.04M
Net Share Change
-1.72M
Activity
1 selling
Investor
Value
Shares
Weight
Change
Oaktree Capital Management
$46.00B
5.04M
0.7%
TRIM
-1.72M
(-25.4%)
Oaktree Capital Management
$46.00B
5.04M shares
TRIM
-1.72M
(-25.4%)
ALVO — Alvotech SA - FilingSpy